Proactiveinvestors Australia Synairgen PLC https://www.proactiveinvestors.com.au Proactiveinvestors Australia Synairgen PLC RSS feed en Fri, 04 Dec 2020 06:59:11 +1100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Small Cap Movers: Pfizer’s positive vaccine news prompts stocks sell-off https://www.proactiveinvestors.com.au/companies/news/933919/small-cap-movers-pfizers-positive-vaccine-news-prompts-stocks-sell-off-933919.html Sat, 14 Nov 2020 10:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/933919/small-cap-movers-pfizers-positive-vaccine-news-prompts-stocks-sell-off-933919.html Proactive news headlines: Synairgen, Alien Metals, Sensyne Health, Vast Resources … https://www.proactiveinvestors.com.au/companies/news/933904/proactive-news-headlines-synairgen-alien-metals-sensyne-health-vast-resources--933904.html Fri, 13 Nov 2020 15:30:00 +1100 https://www.proactiveinvestors.com.au/companies/news/933904/proactive-news-headlines-synairgen-alien-metals-sensyne-health-vast-resources--933904.html Synairgen says inhaled drug formulation could treat patients suffering with coronavirus and flu https://www.proactiveinvestors.com.au/companies/news/933887/synairgen-says-inhaled-drug-formulation-could-treat-patients-suffering-with-coronavirus-and-flu-933887.html Fri, 13 Nov 2020 08:47:00 +1100 https://www.proactiveinvestors.com.au/companies/news/933887/synairgen-says-inhaled-drug-formulation-could-treat-patients-suffering-with-coronavirus-and-flu-933887.html Synairgen plans after £80m share sale to fund crucial trial of breakthrough COVID-19 drug https://www.proactiveinvestors.com.au/companies/news/932064/synairgen-plans-after-80m-share-sale-to-fund-crucial-trial-of-breakthrough-covid-19-drug-932064.html Wed, 21 Oct 2020 14:31:00 +1100 https://www.proactiveinvestors.com.au/companies/news/932064/synairgen-plans-after-80m-share-sale-to-fund-crucial-trial-of-breakthrough-covid-19-drug-932064.html Small Cap Movers: ‘Ten-baggers’ Synairgen, Alien Metals keep up impressive share price runs https://www.proactiveinvestors.com.au/companies/news/931661/small-cap-movers-ten-baggers-synairgen-alien-metals-keep-up-impressive-share-price-runs-931661.html Sat, 17 Oct 2020 09:00:00 +1100 https://www.proactiveinvestors.com.au/companies/news/931661/small-cap-movers-ten-baggers-synairgen-alien-metals-keep-up-impressive-share-price-runs-931661.html Synairgen gets house broker upgrade after impressive fundraise https://www.proactiveinvestors.com.au/companies/news/931675/synairgen-gets-house-broker-upgrade-after-impressive-fundraise-931675.html Fri, 16 Oct 2020 13:03:00 +1100 https://www.proactiveinvestors.com.au/companies/news/931675/synairgen-gets-house-broker-upgrade-after-impressive-fundraise-931675.html Synairgen successfully closes £80mln share sale to fund pivotal trial and manufacturing of breakthrough COVID-19 drug https://www.proactiveinvestors.com.au/companies/news/931502/synairgen-successfully-closes-80mln-share-sale-to-fund-pivotal-trial-and-manufacturing-of-breakthrough-covid-19-drug-931502.html Thu, 15 Oct 2020 06:32:00 +1100 https://www.proactiveinvestors.com.au/companies/news/931502/synairgen-successfully-closes-80mln-share-sale-to-fund-pivotal-trial-and-manufacturing-of-breakthrough-covid-19-drug-931502.html Proactive news headlines: Synairgen, Westminster Group, Jersey Oil & Gas, Powerhouse Energy... https://www.proactiveinvestors.com.au/companies/news/930224/proactive-news-headlines-synairgen-westminster-group-jersey-oil--gas-powerhouse-energy-930224.html Tue, 29 Sep 2020 14:30:00 +1000 https://www.proactiveinvestors.com.au/companies/news/930224/proactive-news-headlines-synairgen-westminster-group-jersey-oil--gas-powerhouse-energy-930224.html Synairgen teams up with Clinigen to provide a managed access programme for Covid treatment https://www.proactiveinvestors.com.au/companies/news/930182/synairgen-teams-up-with-clinigen-to-provide-a-managed-access-programme-for-covid-treatment-930182.html Tue, 29 Sep 2020 06:36:00 +1000 https://www.proactiveinvestors.com.au/companies/news/930182/synairgen-teams-up-with-clinigen-to-provide-a-managed-access-programme-for-covid-treatment-930182.html Synairgen focuses on chronic obstructive pulmonary disease candidate supporting coronavirus programme https://www.proactiveinvestors.com.au/companies/news/219796/synairgen-focuses-on-chronic-obstructive-pulmonary-disease-candidate-supporting-coronavirus-programme-219796.html Tue, 22 Sep 2020 11:35:00 +1000 https://www.proactiveinvestors.com.au/companies/news/219796/synairgen-focuses-on-chronic-obstructive-pulmonary-disease-candidate-supporting-coronavirus-programme-219796.html Synairgen submits patent application for SNG001 treatment https://www.proactiveinvestors.com.au/companies/news/928630/synairgen-submits-patent-application-for-sng001-treatment-928630.html Wed, 09 Sep 2020 07:34:00 +1000 https://www.proactiveinvestors.com.au/companies/news/928630/synairgen-submits-patent-application-for-sng001-treatment-928630.html Market report: FTSE flounders as imminent Brexit talks loom https://www.proactiveinvestors.com.au/companies/news/928525/market-report-ftse-flounders-as-imminent-brexit-talks-loom-928525.html Tue, 08 Sep 2020 10:55:00 +1000 https://www.proactiveinvestors.com.au/companies/news/928525/market-report-ftse-flounders-as-imminent-brexit-talks-loom-928525.html Synairgen unveils positive data from phase II chronic obstructive pulmonary disease trial https://www.proactiveinvestors.com.au/companies/news/928518/synairgen-unveils-positive-data-from-phase-ii-chronic-obstructive-pulmonary-disease-trial-928518.html Tue, 08 Sep 2020 09:13:00 +1000 https://www.proactiveinvestors.com.au/companies/news/928518/synairgen-unveils-positive-data-from-phase-ii-chronic-obstructive-pulmonary-disease-trial-928518.html Synairgen says interim readout supportive of coronavirus programme https://www.proactiveinvestors.com.au/companies/news/928502/synairgen-says-interim-readout-supportive-of-coronavirus-programme-928502.html Tue, 08 Sep 2020 07:32:00 +1000 https://www.proactiveinvestors.com.au/companies/news/928502/synairgen-says-interim-readout-supportive-of-coronavirus-programme-928502.html Demand for healthcare stocks similar to late 90s tech boom, says analyst https://www.proactiveinvestors.com.au/companies/news/926018/demand-for-healthcare-stocks-similar-to-late-90s-tech-boom-says-analyst-926018.html Thu, 06 Aug 2020 11:15:00 +1000 https://www.proactiveinvestors.com.au/companies/news/926018/demand-for-healthcare-stocks-similar-to-late-90s-tech-boom-says-analyst-926018.html BetterLife surges on UK biotech trial results of interferon inhalation treatment for coronavirus https://www.proactiveinvestors.com.au/companies/news/924943/betterlife-surges-on-uk-biotech-trial-results-of-interferon-inhalation-treatment-for-coronavirus-924943.html Thu, 23 Jul 2020 14:21:00 +1000 https://www.proactiveinvestors.com.au/companies/news/924943/betterlife-surges-on-uk-biotech-trial-results-of-interferon-inhalation-treatment-for-coronavirus-924943.html Synairgen boss says SNG001 results “a clearer signal than we could have dared hope for” https://www.proactiveinvestors.com.au/companies/news/924742/synairgen-boss-says-sng001-results-a-clearer-signal-than-we-could-have-dared-hope-for-924742.html Tue, 21 Jul 2020 13:59:00 +1000 https://www.proactiveinvestors.com.au/companies/news/924742/synairgen-boss-says-sng001-results-a-clearer-signal-than-we-could-have-dared-hope-for-924742.html Synairgen PLC's Richard Marsden hails positive results from study on COVID-19 patients https://www.proactiveinvestors.com.au/companies/news/924728/synairgen-plc-s-richard-marsden-hails-positive-results-from-study-on-covid-19-patients-924728.html Tue, 21 Jul 2020 12:49:00 +1000 https://www.proactiveinvestors.com.au/companies/news/924728/synairgen-plc-s-richard-marsden-hails-positive-results-from-study-on-covid-19-patients-924728.html Proactive news headlines: Synairgen, Touchstone Exploration, Shanta Gold, ReNeuron … https://www.proactiveinvestors.com.au/companies/news/924578/proactive-news-headlines-synairgen-touchstone-exploration-shanta-gold-reneuron--924578.html Mon, 20 Jul 2020 14:33:00 +1000 https://www.proactiveinvestors.com.au/companies/news/924578/proactive-news-headlines-synairgen-touchstone-exploration-shanta-gold-reneuron--924578.html Synairgen targets in-home patients for next phase of SNG001 trial https://www.proactiveinvestors.com.au/companies/news/924621/synairgen-targets-in-home-patients-for-next-phase-of-sng001-trial-924621.html Mon, 20 Jul 2020 14:02:00 +1000 https://www.proactiveinvestors.com.au/companies/news/924621/synairgen-targets-in-home-patients-for-next-phase-of-sng001-trial-924621.html Synairgen rockets as trial results could signal "major breakthrough" in treatment of severely ill COVID-19 patients https://www.proactiveinvestors.com.au/companies/news/924546/synairgen-rockets-as-trial-results-could-signal--major-breakthrough--in-treatment-of-severely-ill-covid-19-patients-924546.html Mon, 20 Jul 2020 11:32:00 +1000 https://www.proactiveinvestors.com.au/companies/news/924546/synairgen-rockets-as-trial-results-could-signal--major-breakthrough--in-treatment-of-severely-ill-covid-19-patients-924546.html Market Report: Wobbly FTSE 100 knocked by UK Chinese tensions despite COVID-19 encouragement https://www.proactiveinvestors.com.au/companies/news/924588/market-report-wobbly-ftse-100-knocked-by-uk-chinese-tensions-despite-covid-19-encouragement-924588.html Mon, 20 Jul 2020 10:07:00 +1000 https://www.proactiveinvestors.com.au/companies/news/924588/market-report-wobbly-ftse-100-knocked-by-uk-chinese-tensions-despite-covid-19-encouragement-924588.html Synairgen's Richard Marsden details expansion of home-based coronavirus trial https://www.proactiveinvestors.com.au/companies/news/922290/synairgen-s-richard-marsden-details-expansion-of-home-based-coronavirus-trial-922290.html Fri, 19 Jun 2020 06:01:00 +1000 https://www.proactiveinvestors.com.au/companies/news/922290/synairgen-s-richard-marsden-details-expansion-of-home-based-coronavirus-trial-922290.html Synairgen says coronavirus (COVID-19) trial to be expanded nationally https://www.proactiveinvestors.com.au/companies/news/922188/synairgen-says-coronavirus-covid-19-trial-to-be-expanded-nationally-922188.html Thu, 18 Jun 2020 10:31:00 +1000 https://www.proactiveinvestors.com.au/companies/news/922188/synairgen-says-coronavirus-covid-19-trial-to-be-expanded-nationally-922188.html Synairgen completes hospital recruitment for coronavirus trial https://www.proactiveinvestors.com.au/companies/news/920598/synairgen-completes-hospital-recruitment-for-coronavirus-trial-920598.html Thu, 28 May 2020 07:56:00 +1000 https://www.proactiveinvestors.com.au/companies/news/920598/synairgen-completes-hospital-recruitment-for-coronavirus-trial-920598.html Synairgen CEO details expansion of key coronavirus trial to patients in home https://www.proactiveinvestors.com.au/companies/news/920416/synairgen-ceo-details-expansion-of-key-coronavirus-trial-to-patients-in-home-920416.html Tue, 26 May 2020 13:29:00 +1000 https://www.proactiveinvestors.com.au/companies/news/920416/synairgen-ceo-details-expansion-of-key-coronavirus-trial-to-patients-in-home-920416.html Synairgen gets green light for home study of coronavirus inhaled drug; top line data expected in July https://www.proactiveinvestors.com.au/companies/news/920355/synairgen-gets-green-light-for-home-study-of-coronavirus-inhaled-drug-top-line-data-expected-in-july-920355.html Tue, 26 May 2020 06:37:00 +1000 https://www.proactiveinvestors.com.au/companies/news/920355/synairgen-gets-green-light-for-home-study-of-coronavirus-inhaled-drug-top-line-data-expected-in-july-920355.html Synairgen surges as it extends SNG001 study to coronavirus patients in home environment https://www.proactiveinvestors.com.au/companies/news/918523/synairgen-surges-as-it-extends-sng001-study-to-coronavirus-patients-in-home-environment-918523.html Thu, 30 Apr 2020 11:28:00 +1000 https://www.proactiveinvestors.com.au/companies/news/918523/synairgen-surges-as-it-extends-sng001-study-to-coronavirus-patients-in-home-environment-918523.html Small cap movers: AIM-listed companies raise £500mln in less than a month to cope with coronavirus crisis https://www.proactiveinvestors.com.au/companies/news/918064/small-cap-movers-aim-listed-companies-raise-500mln-in-less-than-a-month-to-cope-with-coronavirus-crisis-918064.html Sat, 25 Apr 2020 09:00:00 +1000 https://www.proactiveinvestors.com.au/companies/news/918064/small-cap-movers-aim-listed-companies-raise-500mln-in-less-than-a-month-to-cope-with-coronavirus-crisis-918064.html Synairgen jumps as SNG001 trial on coronavirus patients labelled as an Urgent Public Health study https://www.proactiveinvestors.com.au/companies/news/917184/synairgen-jumps-as-sng001-trial-on-coronavirus-patients-labelled-as-an-urgent-public-health-study-917184.html Tue, 14 Apr 2020 11:38:00 +1000 https://www.proactiveinvestors.com.au/companies/news/917184/synairgen-jumps-as-sng001-trial-on-coronavirus-patients-labelled-as-an-urgent-public-health-study-917184.html